Follow this preprint
Reinfection with SARS-CoV-2: outcome, risk factors and vaccine efficacy in a Scottish cohort
View ORCID ProfilePaul M McKeigue, View ORCID ProfileDavid A McAllister, View ORCID ProfileChris Robertson, Diane Stockton, View ORCID ProfileHelen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
doi: https://doi.org/10.1101/2021.11.23.21266574
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Paul M McKeigue
aUsher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
David A McAllister
bInstitute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Chris Robertson
cDepartment of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Diane Stockton
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Helen M Colhoun
dInstitute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
ePublic Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE

Data Availability
The component datasets used here are available via application to the Public Benefits and Privacy Panel for Health and Social Care at https://www.informationgovernance.scot.nhs.uk/pbpphsc/. All source code used for derivation of variables, statistical analysis and generation of this manuscript is available on https://github.com/pmckeigue/covid-scotland_public.
Posted November 24, 2021.
Reinfection with SARS-CoV-2: outcome, risk factors and vaccine efficacy in a Scottish cohort
Paul M McKeigue, David A McAllister, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.11.23.21266574; doi: https://doi.org/10.1101/2021.11.23.21266574
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
3
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3136)
- Dermatology (266)
- Emergency Medicine (465)
- Epidemiology (13096)
- Forensic Medicine (14)
- Gastroenterology (872)
- Genetic and Genomic Medicine (4912)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3098)
- Health Policy (1110)
- Hematology (411)
- HIV/AIDS (976)
- Medical Education (458)
- Medical Ethics (121)
- Nephrology (506)
- Neurology (4678)
- Nursing (248)
- Nutrition (692)
- Oncology (2409)
- Ophthalmology (687)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (312)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1252)
- Primary Care Research (526)
- Public and Global Health (7238)
- Radiology and Imaging (1616)
- Respiratory Medicine (946)
- Rheumatology (463)
- Sports Medicine (406)
- Surgery (521)
- Toxicology (65)
- Transplantation (223)
- Urology (193)